Form D · Biotechnology
Aerovance Inc
Berkeley, CA · CIK 0001301697
Offering snapshot reported Mar 18, 2011 · SEC filing
- Reported sold
- $500K Offering amount: $1.62M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 14, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2011 | Initial | $500,000 | No comparison | 17 | SEC filing |
| Sep 20, 2010 | Initial | $2,000,000 | No comparison | 17 | SEC filing |
| Apr 17, 2009 | Initial | $20,000,000 | No comparison | Not reported | SEC filing |
| Apr 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-157015
Source: Form D, filed Mar 18, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Farah Champsi | Director |
| Nicholas G. Galakatos | Director |
| Nick Galakatos | Director |
| Ann Hanham | Director |
| David Happel | Executive |
| Robert Kuhn | Executive |
| Tunde Otulana | Executive |
| Mark Perry | Director, Executive |
| Anthony Rimac | Executive |
| Alain Schreiber | Director |
| John Walker | Director |
| Douglas E. Williams | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2929 Seventh Street Suite 120
Berkeley, CA, 94710
Berkeley, CA, 94710